Pharmaceutical

Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree

Award reflects company’s ongoing commitment to advancing women in leadership and maintaining a gender-equitable cultureDURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE)…

1 year ago

Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023

WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,…

1 year ago

Gracell Biotechnologies Wins Overall Immunology Solution of the Year by BioTech Breakthrough Awards Program

Third annual BioTech Breakthrough Award recognizes excellence in life science and biotechnology solutions, services and companies GC012F, a FasTCAR-enabled autologous…

1 year ago

Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023

WOODCLIFF LAKE, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced…

1 year ago

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2023 Financial Results on November 14, 2023

FREDERICK, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

1 year ago

Government Agencies Emphasize the Importance of Decentralized Methodologies for Future of Clinical Research

Decentralized Trials & Research Alliance brings together Global Leaders for its Annual Meeting SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE)…

1 year ago

Organovo Highlights FXR314 Combination Therapy Potential and Plan

SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is…

1 year ago

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

CIRM-Funded Programs to Receive Access to Avid’s Suite of World-Class CGT CDMO Services to Support Clinical Development ActivitiesTUSTIN, Calif., Nov.…

1 year ago

Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

Phase 1b Study of NXP800 in Patients with Platinum Resistant, ARID1a-Mutated Ovarian Carcinoma is Ongoing Initiated the Phase 1a Dose…

1 year ago

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to…

1 year ago